(MENAFN- EIN Presswire)
Global Antibiotic Resistance Market info
Global Antibiotic Resistance Market seg
Global antibiotic resistance market will be valued at US$ 10.82 Billion in 2021. It is expected to reach US$ 18.34 Billion by 2030
Major market players operating in the Antibiotic Resistance market include Pfizer,Merck, Allergan, Melinta Therapeutics, Arsanis, Debiopharm International SA, Phage Technologies S.A, Westway Health” — Insightace Analytic
NEW JERSEY, NJ, USA, September 9, 2022 /EINPresswire.com / -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the 'Global Antibiotic Resistance Market - by Pathogen (DRSP, DRC, CD, MRSA, DRNG, DRNTS and Other Pathogen), Technology (Antibiotics, Phage, Pep/Lys, Antibodies, Vaccine and Other Technology), Trends, Industry Competition Analysis, Revenue and Forecast To 2030.'
According to the latest research by InsightAce Analytic, the global antibiotic resistance market will be valued at US$ 10.82 Billion in 2021. It is expected to reach US$ 18.34 Billion by 2030, with a CAGR of 6.1% during a forecast period of 2022-2030.
Request for Sample Pages:
Antibiotic usage and abuse are the main causes of antibiotic resistance (ABR). Most antibiotics are available without a prescription, and many people use them that way. The presence of international organizations in developed markets serves as a stimulant, such as BARDA, which offers financial support to biotech businesses to complete early-stage research on novel treatments for antibiotic-resistant illnesses. According to projections, this will provide participants in the global market with new revenue opportunities. For instance, the World Health Organization has designated carbapenem-resistant gram-negative infectious illnesses as a pathogen of concern, necessitating the development of new antibacterial drugs to combat them.
The rise in the prevalence rate of infectious diseases worldwide is one of the key factors anticipated to propel the growth of the antibiotic resistance market during the forecast period. It is also projected that advancements in nutrition, medicines, and vaccination will further fuel the expansion of the antibiotic resistance industry. In contrast, the availability or cost of effective treatments is another factor anticipated to restrain the market's expansion for antibiotic resistance over the forecast period. Additionally, the growing demand for innovative medicines will create additional potential growth possibilities for the antibiotic resistance industry in the years to come. There is potential for the global antibiotic resistance market to grow due to greater cooperation among significant firms for market penetration in the region. The market will expand more quickly in the coming years with increased expenditure in the fight against resistance and implementing ethical usage and stewardship guidelines for antibiotic use. But the lack of skilled workers and tight safety regulations may make the antibiotic resistance market's expansion even more difficult.
North America is anticipated to be the major contributor to the Antibiotic Resistance market over the forecast years due to the market's numerous medicine launches. During the anticipated timeframe, the increase in treatment costs will also contribute to further accelerating the market for antibiotic resistance in the area. In addition, the Europe regional market is expected to register significant growth due to the increase in illnesses that are resistant to antibiotics. Additionally, it is projected that expanding healthcare facilities would further fuel the area's antibiotic resistance market.
Request for ToC/Proposal:
Major market players operating in the Antibiotic Resistance market include The Medicines Company, Melinta Therapeutics, Arsanis, Debiopharm International SA, Phage Technologies S.A, Westway Health, Alaxia SAS, Antabio S.A.S, Auspherix Ltd, NovaBiotics Ltd, BioFilm Pharma, Centauri Therapeutics Ltd, VenatoRx Pharmaceuticals, Combioxin SA, Da Volterra, Deinove, Northern, Antibiotics Oy (Ltd), Nosopharm, Phico Therapeutics Ltd, Polyphor Ltd, Neem Biotech Ltd, QureTech Bio AB,SetLance Srl, Ultupharma AB, Wockhardt Ltd., Vaxdyn, Vibiosphen, Bioaster, Vivexia, Absynth Biologics, KBP Biosciences, Spero Therapeutics, Merck, Symphogen, Warp Drive Bio, Johnson & Johnson (Janssen), Pfizer, Novartis, Allergan, AstraZeneca, Cipla, DSM Sinochem Pharmaceuticals, MicuRx, Entasis Therapeutics, Merlion Pharmaceuticals, Aridis Pharmaceuticals Inc, Other
Recent collaborations and agreements in the market:
•In April 2022, the Holistic Drug Discovery and Development (H3D) Centre at the University of Cape Town welcomed the J&J Satellite Center for Global Health Discovery (Satellite Center), according to a press release from Johnson & Johnson. The H3D Satellite Center will work to create fresh methods to counter the threat of antimicrobial resistance (AMR), which is now present and only getting worse (MDR-GNB).
•In January 2020, Wockhardt became the first Indian pharmaceutical company to get FDA approval for two novel antibiotics, which it plans to launch on the domestic market in the coming months. The Drug Controller General of India (DCGI) has approved Emrok (injectable) and Emrok O (oral) for the treatment of severe bacterial skin and skin structure infections, including diabetic foot infections.
Obtain Report Details @
Market Segments
Global Antibiotic Resistance Market, by Pathogen, 2022-2030 (Value US$ Mn)
•DRSP
•DRC
•CD
•MRSA
•DRNG
•DRNTS
•Other Pathogen
Global Antibiotic Resistance Market, by Technology, 2022-2030 (Value US$ Mn)
•Antibiotics
•Phage
•Pep/Lys
•Antibodies
•Vaccine
•Other Technology
Global Antibiotic Resistance Market, by Region, 2022-2030 (Value US$ Mn)
•North America
•Europe
•Asia Pacific
•Latin America
•Middle East & Africa
North America Antibiotic Resistance Market, by Country, 2022-2030 (Value US$ Mn)
•U.S.
•Canada
Europe Antibiotic Resistance Market, by Country, 2022-2030 (Value US$ Mn)
•Germany
•France
•Italy
•Spain
•Russia
•Rest of Europe
Asia Pacific Antibiotic Resistance Market, by Country, 2022-2030 (Value US$ Mn)
•India
•China
•Japan
•South Korea
•Australia & New Zealand
Latin America Antibiotic Resistance Market, by Country, 2022-2030 (Value US$ Mn)
•Brazil
•Mexico
•Rest of Latin America
Middle East & Africa Antibiotic Resistance Market, by Country, 2022-2030 (Value US$ Mn)
•GCC Countries
•South Africa
•Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global antibiotic resistance market
To receive an industry overview and future trends of the antibiotic resistance market
To analyze the antibiotic resistance market drivers and challenges
To get information on the antibiotic resistance market value (US$ Mn) forecast to 2030
To get information investments, mergers & acquisitions in the antibiotic resistance market industry
For More Information @
Priyanka Tilekar
Insightace Analytic Pvt. Ltd.
+1 551-226-6109
email us here
MENAFN09092022003118003196ID1104838904